164 related articles for article (PubMed ID: 24615187)
1. Radiation recall dermatitis after docetaxel chemotherapy. Treatment by antioxidant ointment.
Duncker-Rohr V; Freund U; Momm F
Strahlenther Onkol; 2014 May; 190(5):491-3. PubMed ID: 24615187
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-induced radiation recall dermatitis : A case report and literature review.
Strouthos I; Tselis N; Zamboglou N
Strahlenther Onkol; 2016 Oct; 192(10):730-6. PubMed ID: 27287082
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-induced radiation recall dermatitis with atypical features: A case report.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N
Medicine (Baltimore); 2018 Sep; 97(36):e12209. PubMed ID: 30200132
[TBL] [Abstract][Full Text] [Related]
4. Case report of cold-weather-induced radiation recall dermatitis after chemoradiotherapy with cisplatin.
Kindts I; Stellamans K; Bonny M; Planckaert N; Goethals L
Strahlenther Onkol; 2014 Aug; 190(8):762-6. PubMed ID: 24699987
[TBL] [Abstract][Full Text] [Related]
5. [Radiation recall dermatitis after oral cyclophosphamide].
Mievis C; Jansen N; Schleich F; Gennigens C; Rorive A; Jérusalem G; Fillet G; Sautois B
Rev Med Liege; 2009 Apr; 64(4):179-81. PubMed ID: 19514535
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel/Cyclophosphamide-Induced Phototherapy Recall.
Ludlow SP; Chehab SS
J Pharm Pract; 2016 Dec; 29(6):569-570. PubMed ID: 26801657
[TBL] [Abstract][Full Text] [Related]
7. Radiation recall dermatitis induced by sorafenib : A case study and review of the literature.
Stieb S; Riesterer O; Brüssow C; Pestalozzi B; Guckenberger M; Weiler S
Strahlenther Onkol; 2016 May; 192(5):342-8. PubMed ID: 26907093
[TBL] [Abstract][Full Text] [Related]
8. [Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
Giesel BU; Kutz GG; Thiel HJ
Strahlenther Onkol; 2001 Sep; 177(9):487-93. PubMed ID: 11591023
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial).
van Dodewaard-de Jong JM; de Klerk JM; Bloemendal HJ; van Bezooijen BP; de Haas MJ; Wilson RH; O'Sullivan JM
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):1990-8. PubMed ID: 21792569
[TBL] [Abstract][Full Text] [Related]
10. Radiation recall dermatitis: A review of the literature.
Bhangoo RS; Cheng TW; Petersen MM; Thorpe CS; DeWees TA; Anderson JD; Vargas CE; Patel SH; Halyard MY; Schild SE; Wong WW
Semin Oncol; 2022 Apr; 49(2):152-159. PubMed ID: 35585004
[TBL] [Abstract][Full Text] [Related]
11. Radiation recall dermatitis from docetaxel.
Piroth MD; Krempien R; Wannenmacher M; Zierhut D
Onkologie; 2002 Oct; 25(5):438-40. PubMed ID: 12415198
[TBL] [Abstract][Full Text] [Related]
12. Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy.
Ford JN; Newton M; Jordan C; Abraham J
J Oncol Pharm Pract; 2013 Mar; 19(1):89-92. PubMed ID: 22323422
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-induced radiation recall dermatitis.
Bourgeois A; Grisoli SB; Soine EJ; Rosen LB
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329490
[TBL] [Abstract][Full Text] [Related]
14. Radiation recall with anticancer agents.
Burris HA; Hurtig J
Oncologist; 2010; 15(11):1227-37. PubMed ID: 21045191
[TBL] [Abstract][Full Text] [Related]
15. An illustrated case of doxorubicin-induced radiation recall dermatitis and a review of the literature.
Haas RL; de Klerk G
Neth J Med; 2011 Feb; 69(2):72-5. PubMed ID: 21411843
[TBL] [Abstract][Full Text] [Related]
16. Radiation recall with vinorelbine and cisplatin.
Zhu ZF; Fan M; Fu XL
Onkologie; 2010; 33(3):107-9. PubMed ID: 20215801
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer.
Mathew P; Thall PF; Jones D; Perez C; Bucana C; Troncoso P; Kim SJ; Fidler IJ; Logothetis C
J Clin Oncol; 2004 Aug; 22(16):3323-9. PubMed ID: 15310776
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-induced radiation recall dermatitis.
Patel NV; Samuels M; Elsayyad N
Head Neck; 2020 Aug; 42(8):E8-E11. PubMed ID: 32270528
[TBL] [Abstract][Full Text] [Related]
19. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
